News Archive | Page 12 of 23 | Lexaria Bioscience Corp.

News

Existing Stock Option and Warrant Exercises for Lexaria

Kelowna, BC / March 10, 2017 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) announces it has received US$82,832.91 from the exercise of stock options and warrants previously granted. The…

Lexaria Signs Master Collaborative Research Agreement

Kelowna, BC / February 8, 2017 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (“the Company” or “Lexaria”), through its wholly owned Canadian subsidiary Lexaria Canpharm Corp., has signed and entered a master collaborative…

CEO Clips Features Lexaria on the BNN Channel

Kelowna, BC / January 31, 2017 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) is currently being featured on CEO Clips airing on BNN. CEO Clips profiles some of the…

Lexaria Extends Investor Relations Agreement

Kelowna, BC / December 22, 2016 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) announces it has extended the services of Frontier Merchant Capital Group (“Frontier”) with a head office…

Lexaria Files International Cannabinoid Patent Applications

Kelowna, BC – December 19, 2016 - Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) is pleased to announce, following the successful October 26, 2016 issuance of its U.S. Patent No.…